default author photo

Manish Sharma

University of Chicago

SCHOLARLY PAPERS

1

DOWNLOADS

38

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

An Open-Label Study to Determine the Maximum Tolerated Dose of Oral ESK-440 Administered as a Single Agent in Patients with Advanced or Metastatic Solid Tumors

Number of pages: 68 Posted: 28 Dec 2023
Russell J. Schilder, Drew Rasco and Manish Sharma
Thomas Jefferson University, South Texas Accelerated Research Therapeutics and University of Chicago
Downloads 38 (1,209,354)

Abstract:

Loading...

Anaplastic lymphoma kinase (ALK), focal adhesion kinase (FAK), solid tumors, ESK-440, tyrosine kinase inhibitor (TKI)